🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of acetaminophen, asserting the companies withheld potential risks that the pain reliever posed to pediatric brain development.

The lawsuit comes thirty days after Donald Trump promoted an unsubstantiated connection between using acetaminophen - also known as acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is taking legal action against J&J, which previously sold the medication, the exclusive pain medication suggested for expectant mothers, and Kenvue, which presently makes it.

In a declaration, he claimed they "deceived the public by making money from pain and marketing drugs ignoring the potential hazards."

Kenvue says there is no credible evidence linking acetaminophen to autism.

"These manufacturers deceived for years, knowingly endangering numerous people to boost earnings," the attorney general, from the Republican party, said.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of American women and children."

On its official site, Kenvue also stated it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between using acetaminophen and autism spectrum disorder."

Associations representing medical professionals and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in acetaminophen - is among limited choices for women during pregnancy to manage pain and fever, which can present major wellness concerns if not addressed.

"In over twenty years of research on the utilization of paracetamol in pregnancy, not a single reputable study has successfully concluded that the usage of acetaminophen in any period of gestation leads to neurodevelopmental disorders in children," the group said.

The court filing cites latest statements from the previous government in arguing the drug is potentially dangerous.

Last month, Trump raised alarms from medical authorities when he instructed women during pregnancy to "fight like hell" not to use acetaminophen when sick.

The FDA then issued a notice that doctors should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism in children has remains unverified.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had vowed in spring to conduct "comprehensive study program" that would determine the cause of autism in a limited time.

But experts warned that discovering a unique factor of autism spectrum disorder - considered by experts to be the consequence of a complex mix of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that influences how persons encounter and engage with the world, and is recognized using physician assessments.

In his court filing, Paxton - a Trump ally who is seeking federal office - claims the manufacturer and J&J "willfully ignored and tried to quiet the research" around acetaminophen and autism.

The lawsuit aims to force the corporations "remove any marketing or advertising" that asserts Tylenol is reliable for women during pregnancy.

This legal action echoes the grievances of a assembly of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in two years ago.

Judicial authorities rejected the legal action, declaring investigations from the parents' expert witnesses was lacking definitive proof.